CINECA IRIS Institutional Research Information System

TIZZANI, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.752
EU - Europa 1.620
AS - Asia 836
AF - Africa 23
SA - Sud America 12
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.248
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.720
CN - Cina 442
SE - Svezia 259
IE - Irlanda 235
DE - Germania 188
UA - Ucraina 183
SG - Singapore 178
FR - Francia 160
FI - Finlandia 142
IT - Italia 137
KR - Corea 121
AT - Austria 112
GB - Regno Unito 86
DK - Danimarca 45
PL - Polonia 34
VN - Vietnam 31
CA - Canada 28
IN - India 26
SN - Senegal 19
BE - Belgio 14
BO - Bolivia 9
IR - Iran 9
ES - Italia 8
TR - Turchia 8
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
ID - Indonesia 4
IQ - Iraq 4
JP - Giappone 4
MU - Mauritius 4
MX - Messico 4
AU - Australia 3
BY - Bielorussia 3
CL - Cile 2
EU - Europa 2
GR - Grecia 2
RS - Serbia 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
BR - Brasile 1
CH - Svizzera 1
IL - Israele 1
LT - Lituania 1
NL - Olanda 1
NO - Norvegia 1
PH - Filippine 1
Totale 5.248
Salva come PNG Salva come JPEG
Città #
Chandler 504
Beijing 342
Houston 285
Dublin 234
Ann Arbor 195
Singapore 138
Jacksonville 135
Villeurbanne 113
Vienna 112
Nyköping 99
Princeton 95
Santa Clara 94
Ashburn 73
Medford 67
Dearborn 62
Columbus 59
Wilmington 50
Fairfield 49
Boston 43
Torino 36
Warsaw 34
Woodbridge 34
Dong Ket 21
Fremont 21
Seattle 21
Munich 20
Milan 19
Washington 18
Redwood City 17
Pune 16
Boardman 15
Toronto 14
Verona 14
Brussels 13
Cambridge 13
New York 12
Pisa 12
Falls Church 11
Guangzhou 11
Mountain View 9
Lachine 8
Nanjing 8
Shanghai 8
Hefei 7
Kunming 7
Des Moines 6
Los Angeles 6
Norwalk 6
San Mateo 6
Tehran 6
Zhengzhou 6
Kharkiv 5
Atlanta 4
Brno 4
Jakarta 4
Jinan 4
Nanchang 4
Ottawa 4
Redmond 4
Auburn Hills 3
Capriolo 3
Detroit 3
Elsenfeld 3
Frankfurt am Main 3
Hubert 3
Kashan 3
London 3
Phoenix 3
San Diego 3
Seoul 3
Tappahannock 3
Antalya 2
Athens 2
Bologna 2
Catanzaro 2
Düsseldorf 2
Feasterville 2
Grafing 2
Hamburg 2
Hangzhou 2
Linköping 2
Makkah 2
Malonno 2
Mumbai 2
Mus 2
Olathe 2
Paris 2
Parma 2
Quzhou 2
Rancagua 2
Reading 2
Sacramento 2
Saint-Fons 2
Sandwich 2
Sarasota 2
Shenyang 2
Shenzhen 2
Stockholm 2
Tokyo 2
Ascoli Piceno 1
Totale 3.330
Salva come PNG Salva come JPEG
Nome #
Pharmacokinetic study to optimize the intravesical administration of gemcitabine 285
Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison. 180
Critical issues in current comparative and cost analyses between retropubic and robotic radical prostatectomy 149
A Pharmacokinetics Study to Optimize Intravesical Administration of Gemcitabine 144
Prostatectomy restores the maturation competence of blood dendritic cell precursors and reverses the abnormal expansion of regulatory T lymphocytes. 135
Proposal of an improved prognostic classification for pT3 renal cell carcinoma 134
SINGLE NUCLEOTIDE POLYMORPHISMS (SNP) AND HAPLOTYPES IN PSA PROMOTER: A NEW PROMISING PROSTATE CANCER SUSCEPTIBILITY AND PROGNOSIS PREDICTOR TOOL 113
Confronto tra due metodi per la misura della concentrazione della cromogranina A circolante in pazienti con iperplasia prostatica benigna e adenocarcinoma prostatico 111
Osteoclasts are active in bone forming metastases of prostate cancer patients 109
Does kidney transplantation onto the external iliac artery affect the haemodynamic parameters of the cavernosal arteries? 107
Chromogranine A serum levels in patients affected by prostate cancer and benign prostate hypertrophy: comparison between two different commercial kits 107
[A case of percutaneous translumbar clearance of an obstructed ureterocutaneostomy] 103
A pilot phase-II prospective study to test the 'efficacy' and tolerability of a penile-extender device in the treatment of 'short penis' 99
Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation 98
Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder. 96
Effect of finasteride on the sensitivity of PSA to detect prostate cancer in rebiopsy series. 96
Circadian antidiuretic hormone variation in elderly men complaining of persistent nocturia after urinary flow obstruction removal. 93
A pharmacokinetics study to optimize intravesical administration of gemcitabine 92
Comparison between two commercially available chromogranin A assays in detecting neuroendocrine differentiation in prostate cancer and benign prostate hyperplasia 87
Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer. 85
Detection of estrogen receptors in the trigonum and urinary bladder with an immunohistochemical technique. 85
Progression from superficial to invasive carcinoma of the bladder: genetic evidence of either clonal heterogeneous events. 84
RNASEL R462Q is significantly associated with Prostate Cancer in the Italian population 83
125I brachytherapy for localized prostate cancer: a single institution experience 83
Activity of weekly paclitaxel in advanced hormone-refractory prostate cancer 82
[A new needle-catheter for percutaneous pyelostomy] 81
Ablative therapies in the treatment of small renal tumors: how far from standard of care? 81
Prognostic factors of 'high-grade' Ta bladder cancers according to the WHO 2004 classification: are these equivalent to 'high-risk' non-muscle-invasive bladder cancer? 80
[Note on a personal technic for percutaneous and endoscopic placement of a double J urinary prosthesis] 79
BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder. 78
Significato prognostico della sottoclassificazione dello stadio T1 nei carcinomi uroteliali di alto grado della vescica: studio multicentrico dell'Associazione Urologi Piemontesi e Valdostani (AUP) 78
The hidden life of NAD+-consuming ectoenzymes in the endocrine system. 77
Longer operative time and hospital stay are associated with post operative cystectomy complications: a modified Clavien classification system analysis. 76
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study. 75
Tobacco smoke, recurrences, and p53/bcl-2 expression in bladder cancer. 74
EVALUATION OF POSTOPERATIVE RADICAL CYSTECTOMY COMPLICATIONS: A MODIFIED CLAVIEN CLASSIFICATION SYSTEM ANALYSIS 73
EVALUATION OF TRANSURETHRAL BLADDER RESECTION COMPLICATIONS: A MODIFIED CLAVIEN CLASSIFICATION SYSTEM ANALYSIS 70
Update on epidemiology and risk factors of prostate cancer 69
PHARMACOKINETICS, PHARMACOLOGICAL STABILITY AND SAFETY OF MMC ADMINISTERED WITH A NEW HYPERTHERMIA DEVICE 68
The genetic alterations in the oncogenic pathway of transitional cell carcinoma of the bladder and its prognostic value. 66
Metallic stents in ureteral obstructio: our experience 62
[Screening for prostate cancer: reasons for, reasons against] 61
DNA flow cytometry and 67Ki proliferating index as prognostic factors of early recurrence and progression in G1-G2/Ta-T1 and G3/Ta-T1 transitional cell carcinoma of the bladder. 61
Prognostic factors in a prospective series of papillary renal cell carcinoma 59
Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer 56
Percutaneous US-guided RF thermal ablation for malignant renal tumors: preliminary results in 13 patients 55
RNASEL Arg462Gln is significantly associated with Prostate cancer in the Italian population 55
Efficacy and safety of Tadalafil 20 mg on demand vs. Tadalafil 5 mg once-a-day in the treatment of post-radiotherapy erectile dysfunction in prostate cancer men: a randomized phase II trial. 54
Fatal haematuria in a patient with an orthotopic neobladder and chronic liver failure 51
Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma 51
Phase II study to investigate the ablative efficacy of intravesical administration of gemcitabine in intermediate-risk superficial bladder cancer (SBC) 50
ESWL dei calcoli del calice inferiore: un trattamento superato? 50
Primary bladder phaeochromocytoma diagnosed by a vet 49
Retroperitoneal laparoscopic kidney biopsy: technical tips for a minimally invasive approach. 49
New insights into the pathogenesis of penile shortening after radical prostatectomy and the role of postoperative sexual function 46
External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinoma. 46
Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients 45
Use of penile extender device in the treatment of penile curvature as a result of Peyronie's disease. Results of a phase II prospective study 45
p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder. 45
Pathological features and adverse prognosis of a contemporary series of neuroendocrine bladder tumours. 44
Male and female sexual dysfunction (SD) after radical pelvic urological surgery 43
Is there a prostate-specific antigen upper limit for radical prostatectomy? 43
Effect of inhibitors on the crystal growth of calcium oxalate 42
Immunohistochemical evaluation of the safety of transurethral electrovaporization of the prostate and its clinical results. 40
Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? 40
Multipathogenetic origin of a pelvic mass. 39
Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. 37
Prostatic duct carcinoma with combined prostatic duct adenocarcinoma and urothelial carcinoma features: report of a case 36
Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer. 35
Immunohistochemical detection of estrogen and progesterone receptors in the normal urinary bladder and in pseudomembranous trigonitis. 34
New drugs currently available in non-muscle invasive bladder cancer: update on gemcitabine studies. 31
La nefrectomia laparoscopica eseguita con tecnica Gasless 8
Quality of life in elderly bladder cancer patients following cystectomy and urinary diversion 5
Totale 5.432
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.455
article - articoli 0
book - libri 0
conference - conferenze 3.676
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.131
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020620 0 0 0 0 66 239 81 19 56 67 47 45
2020/2021464 65 25 29 17 38 19 50 27 69 42 29 54
2021/2022678 15 25 26 75 19 21 43 34 26 37 179 178
2022/20231.182 159 169 14 142 90 289 92 46 100 30 28 23
2023/2024364 56 68 37 21 21 47 27 17 0 5 15 50
2024/2025457 15 112 28 129 173 0 0 0 0 0 0 0
Totale 5.432